Harvard Apparatus Regenerative Technology,
Why Robinhood?
You can watch HRGN and buy or sell other stocks, ETFs, and their options commission-free!About HRGN
Harvard Apparatus Regenerative Technology, Inc. is a clinical-stage biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. The company was founded by David Green on May 3, 2012 and is headquartered in Holliston, MA.
HRGN Key Statistics
Stock Snapshot
Harvard Apparatus Regenerative Technology,(HRGN) stock is priced at $1.50, giving the company a market capitalization of 26.37M. It carries a P/E multiple of -3.60.
On 2026-05-14, Harvard Apparatus Regenerative Technology,(HRGN) stock opened at —, reached a high of —, and a low of —.
The Harvard Apparatus Regenerative Technology,(HRGN)'s current trading volume is 0, compared to an average daily volume of 838.1.
During the past year, Harvard Apparatus Regenerative Technology,(HRGN) stock moved between $0.94 at its lowest and $2.22 at its peak.
During the past year, Harvard Apparatus Regenerative Technology,(HRGN) stock moved between $0.94 at its lowest and $2.22 at its peak.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.